CTVA - Corteva, Inc. Stock Analysis | Stock Taper
Logo
Corteva, Inc.

CTVA

Corteva, Inc. NYSE
$80.12 1.65% (+1.30)

Market Cap $53.88 B
52w High $80.22
52w Low $53.40
Dividend Yield 1.05%
Frequency Quarterly
P/E 45.78
Volume 3.09M
Outstanding Shares 672.52M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $3.91B $1.27B $-552M -14.12% $-0.82 $-178M
Q3-2025 $2.62B $1.28B $-320M -12.22% $-0.47 $-24M
Q2-2025 $6.46B $1.69B $1.31B 20.35% $1.93 $2.16B
Q1-2025 $4.42B $1.25B $652M 14.76% $0.95 $1.12B
Q4-2024 $3.98B $1.16B $-41M -1.03% $-0.06 $450M

What's going well?

Revenue surged 49% and the company swung to an operating profit, showing strong demand and better efficiency. Gross margins also improved slightly, and cost control looks solid.

What's concerning?

A large 'other' expense wiped out operating gains, leading to a bigger net loss. The bottom line is still negative, and one-off items are distorting results.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $4.53B $42.84B $18.46B $24.14B
Q3-2025 $2.59B $42.2B $16.74B $25.22B
Q2-2025 $2.14B $41.76B $15.61B $25.91B
Q1-2025 $2.01B $42.12B $17.6B $24.29B
Q4-2024 $3.17B $40.83B $16.8B $23.79B

What's financially strong about this company?

Cash jumped by 75% and debt was cut nearly in half, leaving the company with more cash than debt. Most liabilities are long-term, and the company is collecting from customers faster.

What are the financial risks or weaknesses?

Retained earnings turned negative, meaning recent losses wiped out past profits. Equity fell, and nearly half of assets are intangible, which could be risky if acquisitions disappoint.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-552M $4.38B $-188M $-2.2B $1.78B $4.15B
Q3-2025 $-395M $193M $-157M $367M $420M $36M
Q2-2025 $1.38B $947M $-164M $-808M $22M $829M
Q1-2025 $667M $-2.11B $-34M $995M $-1.13B $-2.2B
Q4-2024 $-52M $4.17B $-123M $-3.34B $666M $3.99B

What's strong about this company's cash flow?

The company generated a massive amount of cash this quarter, easily covering all expenses, debt repayments, and shareholder returns. Cash flow quality is high, with real cash coming in, not just accounting profits.

What are the cash flow concerns?

Much of the cash flow jump came from one-time working capital changes, which may not repeat. Net income remains negative, so underlying profitability is still a concern.

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Biologicals
Biologicals
$80.00M $100.00M $150.00M $190.00M
Crop Protection
Crop Protection
$1.71Bn $1.92Bn $1.70Bn $2.17Bn
Fungicides
Fungicides
$300.00M $340.00M $220.00M $270.00M
Herbicides
Herbicides
$860.00M $990.00M $810.00M $1.06Bn
Insecticides
Insecticides
$340.00M $440.00M $410.00M $490.00M
Other
Other
$130.00M $50.00M $110.00M $160.00M
Seed
Seed
$2.71Bn $4.54Bn $920.00M $1.74Bn

Revenue by Geography

Region Q1-2019Q2-2025Q3-2025
Crop Protection
Crop Protection
$0 $520.00M $770.00M
Seed
Seed
$0 $280.00M $390.00M
Asia Pacific
Asia Pacific
$1.46Bn $0 $0
E M E A
E M E A
$2.11Bn $0 $0
Latin America
Latin America
$470.00M $0 $0
UNITED STATES
UNITED STATES
$2.25Bn $0 $0

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Corteva, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Corteva combines a steadily growing revenue base with improving operating margins, supported by strong recent performance in operating and free cash flow. Its balance sheet is conservative, with solid liquidity and relatively low leverage, giving it flexibility to navigate agricultural cycles. Competitively, it benefits from powerful brands, a global distribution network, and a large portfolio of patented traits and crop protection products, all reinforced by substantial and rising R&D investment. The company’s integrated approach—seeds, crop protection, biologicals, and digital tools—creates a differentiated offering and deep customer relationships.

! Risks

Key risks include volatile earnings, as net income and earnings per share have not yet regained earlier highs despite better operating performance, and retained earnings have slipped into negative territory, reflecting an uneven history of profitability and capital returns. Rising overhead costs and growing short-term liabilities point to ongoing pressure on margins and working capital. At the industry level, Corteva faces intense competition, patent expirations, regulatory scrutiny of seeds and chemicals, and exposure to commodity prices and weather patterns. The planned separation of its seed and crop protection businesses introduces additional strategic and operational execution risk.

Outlook

The overall picture is of a financially sound, innovation-driven agriscience company with improving cash-generation and a strong competitive platform, but with earnings volatility and execution challenges that cannot be ignored. If Corteva can sustain recent gains in operating and free cash flow, keep overhead in check, and smoothly manage its business separation while continuing to deliver high-value innovations, its financial profile could gradually strengthen. At the same time, the agricultural sector’s inherent cyclicality and regulatory intensity mean that performance is likely to remain uneven year to year, even if the long-term demand for higher-yield, more sustainable farming practices continues to provide a supportive backdrop.